The xeroderma pigmentosum complementation group A (XP-A) protein, XPA, has recently been expressed In Escherichia colU In a soluble and fully functional form. An afiMnit column was prepared by lk the XPA protein to a solid support. When HeLa cell-free extrat capable of excision repair was applied to the column, >99.9% of the proteins were in the flow-through. However, the flow-through fraction lacked excision activity. The activity was restored by adding the hig salt (1 M KCI) eluate of the column to the flow-through action. The XPA protein-bound fraction was tested for specific proteins by an in vitro complementation assay with a panel of cell-free extracts from DNA repair-deficient human and rodent celi lines. The XPA-bound fraction complemented cell-free extracts of excision repair cross-complementing 1 (ERCC-1), ERCC-4 (XP-F), and XP-A mutants. We conciude that the XPA damage recognition protein makes a ternary complex with the ERCC1/ERCC4(XPF) heterodimer with a potential nuclease function.
Xeroderma pigmentosum (XP) is a hereditary disease characterized by photosensitivity, high incidence of actinic cancers, and, in some cases, neurological abnormalities (1) . The biochemical basis of XP is a defect in nucleotide-excision repair (2, 3) . Somatic cell genetics of cell lines from XP patients (4) and of UV-sensitive rodent cell lines isolated in the laboratory (5) have identified at least eight genes which are involved in the incision step ofexcision repair: XPA-XPG and ERCCI* (6, 7) . Excision repair in humans encompasses two basic processes, damage recognition and dual incisions on either side of the lesion (8) . Of the eight known excision repair proteins, some must be involved in damage recognition and priming of DNA in terms of inducing the proper conformational change for the nuclease subunit(s) to bind and carry out the incision reactions.
The XPA protein is known to be involved in damage recognition (9) (10) (11) , and the gene sequence reveals a zinc finger which might be important for DNA binding (10, 12) . We recently reported expression of XPA protein in a soluble form in a heterologous system and purification of and complementation with the overexpressed protein (6) . The purified protein binds to DNA but has no other detectable activity. Thus, it must interact with the other subunits to bring about the excinuclease (an enzyme which removes DNA lesions in an oligonucleotide by incising the damaged strand on both sides of the lesion) function. To identify the subunits which interact with the XPA protein we made an XPA affinity column, applied cell-free extract (CFE) to it and tested the unbound and bound fractions for activity. We found that the bound fraction contained the ERCC1, ERCC4(XPF), and XPA proteins. These results, combined with the data suggesting that ERCC1 and ERCC4(XPF) make a tight complex (7) and with the detection ofXPA-ERCC1 interaction by the yeast two-hybrid system (13) (14) and stored at -800C until use. The substrate was covalently closed plasmid DNA containing four thymine dimers and 32P-label at the 11th phosphodiester bond 5' to the thymine dimers (15, 16) . The thymine dimer-containing oligomer used to make the substrate was a gift of J.-S. Taylor (Washington University, St. Louis).
Purifiation of Fusion Proteins. The maltose-binding protein (MBP)-XPA and MBP-ERCC1 fusion proteins were purified through amylose and heparin-agarose columns from 6-liter cultures of Escherichia coli DR153/pMAL-XPA and DHSa F' lacIq/pMAL-ERCC1, respectively, as described previously (6) . MBP in the form of a MBP-f-galactosidase a peptide ((gala) fusion was purified from a 1-liter culture of DH5a F' lacIq/pMAL-c2 as described (6 was not augmented by addition ofthe "bound" fraction to the unbound protein (lanes 3 and 4). In fact with this control column the level of "bound" protein was at our detection limit, indicating that MBP does not bind nonspecifically to human proteins in the CFE.
In contrast, when a similar experiment was performed with the MBP-XPA affinity column, the unbound fraction was greatly depleted of excision activity (Fig. 1, lane 5) . Addition of the bound fraction from the MBP column did not restore the excision activity (lane 6). However, addition of the XPA-bound fraction (which by itself had no excinuclease activity; data not shown) restored excision to a level that we have typically observed (7) (Fig. 1, lanes 1 and 2) and this activity conditions ERCC1 was not retained by the (MBP)-Affi-Gel 10 affinity column (data not shown). These results suggest that XPA protein binds to the ERCC1/ERCC4(XPF) complex through its interaction with ERCC1 protein but do not eliminate the possibility that XPA interacts with ERCC4(XPF) directly or when the latter protein is in the form of an ERCC1/ERCC4(XPF) complex.
Lack of Damage-Specific Nuclease Activity in the XPA/ERCC1/ERCC4(XPF) Complex. The XPA protein (9) and especially its yeast homolog RAD14 (10) bind preferentially to UV-damaged DNA. Furthermore, the yeast ERCC1 homolog RAD10 (17) and possible ERCC4 homolog RAD1 (7) make a tight complex with endonuclease activity specific for single-stranded and negatively supercoiled duplex DNA (18, 19) . Therefore, it was conceivable that the XPA/ERCC1/ ERCC4(XPF) complex would be targeted to the damage site by the XPA and would enable ERCC1/ERCC4(XPF) to act as a damage-specific endonuclease (10, 20) . We tested this possibility by incubating supercoiled DNA with the bound fraction of the XPA affinity column, which has ERCC-1-, ERCC-4-, and XP-A-complementing activity. The results are shown in Fig. 4 . Under conditions where the XPA-bound fraction complemented CFEs from all three mutant cell lines, no specific nicking of the damaged DNA was observed. These results suggest that the XPA/ERCC1/ERCC4(XPF) complex needs the aid of the other XP proteins to carry out damagespecific incision of DNA even on one side of the lesion. 6 and 9-12 ). Lanes 3, 4, 9, and 10, HeLa CFE bound fractions (two different batches were applied to lanes 3 and 9 and lanes 4 and 10); lanes 5 and 11, ERCC-1 CFE bound fractions; lanes 6 and 12, ERCC-4 CFE bound fractions. Following incubation ofDNA with the "affinity-purified" proteins, the reaction products were analyzed by electrophoresis in a 1% agarose gel. OC, open circular DNA; CC, covalently closed superhelical DNA. Control experiments with unfractionated HeLa CFE caused extensive nicking of DNA by nonspecific nucleases (21) .
DISCUSSION
Human excinuclease is an ATP-dependent multisubunit enzyme system which removes damaged bases from DNA by incising the 21st to 23rd phosphodiester bond 5' and the 5th phosphodiester bond 3' to the lesion (15, 16) . While this excision mechanism differs from the prokaryotic pattern only in the distance between the lesion and the 5' incision site (the 8th phosphodiester bond to the lesion in E. coli) the human system entails 8-10 subunits compared with only 3 subunits in E. coli. Apparently, in the human excinuclease system more polypeptides are required to target the subunits with the nuclease active site to their respective phosphodiester bonds. Recent work with the yeast homologs of human excision repair proteins has identified two potential nucleases: the RAD1/RAD10 complex, which is the yeast counterpart ofthe ERCC4(XPF)/ERCC1 complex (18, 19) and the RAD2 protein, which is homologous to XPG (20) . The remaini subunits presumably act as molecular matchmakers (22) for the nuclease components.
Thus, the finding that the potential nuclease, ERCC4(XPF)/ERCC1, binds to the damage recognition subunit, XPA, was of considerable interest. This finding, in turn, raises several issues which must be clarified in order to understand the molecular mechanism of human excinuclease. Some of these issues are addressed below.
Binding of XPA to ERCC1/ERCC4(XPF) Cbmplex. Our data suggest that XPA interacts with the ERCC1 component of the heterodimer. Li et al. (13) (preceding paper in this issue) have found that both in the in vivo two-hybrid system and in an in vitro transcription/translation system, XPA interacts with ERCC1 and have narrowed down the interaction site to the amino-terminal halves of the two proteins. Although these studies by themselves could not eliminate the possibility of interaction of ERCC1 with XPA via a third protein, the finding reported in this paper shows binding of ERCC1 to XPA in the absence of other human proteins. Thus, we conclude that XPA directly binds ERCC1, which in turn binds ERCC4(XPF). Furthermore, since the carboxylterminal half of RADi binds to the carboxyl-terminal half of RAD10 (23, 24) we consider the interaction scheme in Fig. 5 as a likely model for the interaction of these three subunits:
the amino-terminal half of XPA binds to the amino-terminal halfofERCC1 (13) , whose carboxyl-terminal halfbinds to the carboxyl-terminal half of ERCC4(XPF).
Stability of the Ternary Complex. It was not surprising to find that ERCC1 and ERCC4(XPF) copurify because previ- (13). The interaction between the carboxyl termini of ERCC1 and ERCC4(XPF) is assumed based on the findings with the yeast homologs of these proteins, RAD10 and RAD1 (24) .
ous work strongly suggested that these two subunits make a tight complex in humans (7), and in the yeast system such a complex was directly demonstrated with purified subunits (23, 24) . However, interaction ofthis complex with XPA was not expected. First, the yeast XPA homolog RAD14 has been purified (10) and no interaction with the RAD1/RAD10 complex was reported. Second, the XPA protein was purified from calfthymus free ofother XP proteins (9, 25) . We suspect that the interaction of ERCC1 with XPA is not as strong as its interaction with ERCC4(XPF), and as a consequence the XPA protein becomes separated from the ERCC1/ ERCC4(XPF) complex by the ion-exchange chromatography employed to purify the XPA protein. This is consistent with the finding that XPA-CFE is complemented by CFE of ERCC1 or ERCC4, in contrast to the lack of complementation between ERCC1 and ERCC4 extracts (7) . However, we do believe that this interaction is specific and functionally significant because of all ofthe XP proteins only the ERCC1/ ERCC4(XPF) complex (in addition to XPA) was removed by XPA affinity chromatography.
Rentin of XPA by the XPA Affinity Column. Purified XPA protein behaves as a protein of40 kDa by gel permeation chromatography (11, 25) (19) . We failed to detect such an activity with the affinity-purified XPA/ ERCC1/ERCC4(XPF) complex. The following are possible explanations. First, the concentration of the complex might be too low to detect an endonuclease activity at levels comparable to that seen with the relatively high concentrations of RAD1/RAD10 complex used in the purified system. Second, the XPA protein in the ternary complex might suppress the nonspecific endonuclease of the nonphysiological ERCC1/ERCC4(XPF) complex and convert it into a damage-specific endonuclease. However, such a damagespecific activity was not observed under our assay conditions. Furthermore, since under these conditions the affinitypurified ternary complex complemented CFEs from all three mutant cell lines, we conclude that the lack of specific nicking of damaged DNA is due to the fact that in humans specific nicking requires more than these three subunits.
Purcation of ERCC1/ERCC4(XPF) Complex by Affinity Chromatography. To define the functions of the individual subunits of human excinuclease it might be necessary to purify all of the subunits and reconstitute the enzyme in a defined system. The ERCCI gene has been cloned (17) and the protein has been expressed in and purified from E. coli in a functional form (6) . Similarly, the XPA protein has been expressed in E. coli (6, 11, 26) , and mutant CFE has been complemented with the protein made in E. coli. In contrast, a cDNA clone of XPF is not available yet. Therefore, the affinity chromatography system described here offers an alternative method to purify this protein in its functionally relevant complex form. Indeed, a simple calculation taking into account that of the 3 mg of HeLa CFE applied to the column only about 1-3 ug was bound and that the bound fraction contained essentially all of the ERCC1/ ERCC4(XPF) activity reveals that a >1000-fold purification is achieved in a single step. One to two additional purification steps after preparative-scale affinity chromatography should yield pure protein that can be used in further physical and biochemical characterization.
